SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC
http://www.w3.org/2000/01/rdf-schema#comment
"Results suggest that PAR-1622 is a selective partial activator of PPARgamma and has excellent antihyperglycemic activities and a broad safety profile for fluid retention."
xsd:string
http://purl.uniprot.org/uniprot/#_939E4D5D6B783A2DD08C944434DA4B2E31CC44D6EB2BC1B76D0728BDF10D66AE898D33B0E5B118313E58347D9F2320E1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC
http://purl.uniprot.org/uniprot/Q6TQE4
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC
http://purl.uniprot.org/uniprot/#_Q6TQE4-mappedCitation-19471887
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/1F0D0BEC61468EF49E9C9CCFD9DA067A7E51D9A40AC038555A7DD160F8060C52C8F783145CFD12D725345999ECE1DABC